Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement. Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint, including analgesics, nonsteroidal anti-inflammatory drugs, corticosteroids, hyaluronic acid, and phase III drugs.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Osteoarthritis Drugs market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Osteoarthritis Drugs market. Detailed analysis of key players, along with key growth strategies adopted by Osteoarthritis Drugs industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sanofi
Pfizer
Johnson & Johnson
Abbott
GlaxoSmithKline
Flexion Therapeutics
Eli Lilly
By Type:
Oral
Injection
External
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Osteoarthritis Drugs Market
-
1.3 Market Segment by Type
-
1.3.1 China Osteoarthritis Drugs Market Size and Growth Rate of Oral from 2016 to 2027
-
1.3.2 China Osteoarthritis Drugs Market Size and Growth Rate of Injection from 2016 to 2027
-
1.3.3 China Osteoarthritis Drugs Market Size and Growth Rate of External from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Osteoarthritis Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
1.4.2 China Osteoarthritis Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
1.4.3 China Osteoarthritis Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Osteoarthritis Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Osteoarthritis Drugs by Major Types
-
3.4.1 Market Size and Growth Rate of Oral
-
3.4.2 Market Size and Growth Rate of Injection
-
3.4.3 Market Size and Growth Rate of External
4 Segmentation of Osteoarthritis Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Osteoarthritis Drugs by Major End-Users
-
4.4.1 Market Size and Growth Rate of Osteoarthritis Drugs in Hospital Pharmacies
-
4.4.2 Market Size and Growth Rate of Osteoarthritis Drugs in Retail Pharmacies
-
4.4.3 Market Size and Growth Rate of Osteoarthritis Drugs in Online Pharmacies
5 Market Analysis by Regions
-
5.1 China Osteoarthritis Drugs Production Analysis by Regions
-
5.2 China Osteoarthritis Drugs Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Osteoarthritis Drugs Landscape Analysis
-
6.1 North China Osteoarthritis Drugs Landscape Analysis by Major Types
-
6.2 North China Osteoarthritis Drugs Landscape Analysis by Major End-Users
7 Central China Osteoarthritis Drugs Landscape Analysis
-
7.1 Central China Osteoarthritis Drugs Landscape Analysis by Major Types
-
7.2 Central China Osteoarthritis Drugs Landscape Analysis by Major End-Users
8 South China Osteoarthritis Drugs Landscape Analysis
-
8.1 South China Osteoarthritis Drugs Landscape Analysis by Major Types
-
8.2 South China Osteoarthritis Drugs Landscape Analysis by Major End-Users
9 East China Osteoarthritis Drugs Landscape Analysis
-
9.1 East China Osteoarthritis Drugs Landscape Analysis by Major Types
-
9.2 East China Osteoarthritis Drugs Landscape Analysis by Major End-Users
10 Northeast China Osteoarthritis Drugs Landscape Analysis
-
10.1 Northeast China Osteoarthritis Drugs Landscape Analysis by Major Types
-
10.2 Northeast China Osteoarthritis Drugs Landscape Analysis by Major End-Users
11 Southwest China Osteoarthritis Drugs Landscape Analysis
-
11.1 Southwest China Osteoarthritis Drugs Landscape Analysis by Major Types
-
11.2 Southwest China Osteoarthritis Drugs Landscape Analysis by Major End-Users
12 Northwest China Osteoarthritis Drugs Landscape Analysis
-
12.1 Northwest China Osteoarthritis Drugs Landscape Analysis by Major Types
-
12.2 Northwest China Osteoarthritis Drugs Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Sanofi
-
13.1.1 Sanofi Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer
-
13.2.1 Pfizer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Johnson & Johnson
-
13.3.1 Johnson & Johnson Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Abbott
-
13.4.1 Abbott Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 GlaxoSmithKline
-
13.5.1 GlaxoSmithKline Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Flexion Therapeutics
-
13.6.1 Flexion Therapeutics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Eli Lilly
-
13.7.1 Eli Lilly Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Osteoarthritis Drugs Market Size and Growth Rate of Oral from 2016 to 2027
-
Figure China Osteoarthritis Drugs Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure China Osteoarthritis Drugs Market Size and Growth Rate of External from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Osteoarthritis Drugs Market Size and Growth Rate of Hospital Pharmacies from 2016 to 2027
-
Figure China Osteoarthritis Drugs Market Size and Growth Rate of Retail Pharmacies from 2016 to 2027
-
Figure China Osteoarthritis Drugs Market Size and Growth Rate of Online Pharmacies from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Osteoarthritis Drugs Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Osteoarthritis Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Osteoarthritis Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Osteoarthritis Drugs by Different Types from 2016 to 2027
-
Table Consumption Share of Osteoarthritis Drugs by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Oral
-
Figure Market Size and Growth Rate of Injection
-
Figure Market Size and Growth Rate of External
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Osteoarthritis Drugs by Different End-Users from 2016 to 2027
-
Table Consumption Share of Osteoarthritis Drugs by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital Pharmacies
-
Figure Market Size and Growth Rate of Retail Pharmacies
-
Figure Market Size and Growth Rate of Online Pharmacies
-
Table China Osteoarthritis Drugs Production by Regions
-
Table China Osteoarthritis Drugs Production Share by Regions
-
Figure China Osteoarthritis Drugs Production Share by Regions in 2016
-
Figure China Osteoarthritis Drugs Production Share by Regions in 2021
-
Figure China Osteoarthritis Drugs Production Share by Regions in 2027
-
Table China Osteoarthritis Drugs Consumption by Regions
-
Table China Osteoarthritis Drugs Consumption Share by Regions
-
Figure China Osteoarthritis Drugs Consumption Share by Regions in 2016
-
Figure China Osteoarthritis Drugs Consumption Share by Regions in 2021
-
Figure China Osteoarthritis Drugs Consumption Share by Regions in 2027
-
Table North China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table North China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure North China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure North China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure North China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table North China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table North China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure North China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure North China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure North China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table Central China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table Central China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure Central China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure Central China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure Central China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table Central China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table Central China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure Central China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure Central China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table South China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table South China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure South China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure South China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure South China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table South China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table South China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure South China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure South China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure South China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table East China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table East China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure East China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure East China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure East China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table East China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table East China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure East China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure East China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure East China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table Northeast China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table Northeast China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure Northeast China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure Northeast China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table Northeast China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table Northeast China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure Northeast China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure Northeast China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table Southwest China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table Southwest China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure Southwest China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure Southwest China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table Southwest China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table Southwest China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure Southwest China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure Southwest China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table Northwest China Osteoarthritis Drugs Consumption by Types from 2016 to 2027
-
Table Northwest China Osteoarthritis Drugs Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Osteoarthritis Drugs Consumption Share by Types in 2016
-
Figure Northwest China Osteoarthritis Drugs Consumption Share by Types in 2021
-
Figure Northwest China Osteoarthritis Drugs Consumption Share by Types in 2027
-
Table Northwest China Osteoarthritis Drugs Consumption by End-Users from 2016 to 2027
-
Table Northwest China Osteoarthritis Drugs Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Osteoarthritis Drugs Consumption Share by End-Users in 2016
-
Figure Northwest China Osteoarthritis Drugs Consumption Share by End-Users in 2021
-
Figure Northwest China Osteoarthritis Drugs Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Johnson & Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson
-
Figure Revenue and Market Share Analysis of Johnson & Johnson
-
Table Product and Service Introduction of Johnson & Johnson
-
Table Company Profile and Development Status of Abbott
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
-
Figure Sales and Growth Rate Analysis of Abbott
-
Figure Revenue and Market Share Analysis of Abbott
-
Table Product and Service Introduction of Abbott
-
Table Company Profile and Development Status of GlaxoSmithKline
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline
-
Table Product and Service Introduction of GlaxoSmithKline
-
Table Company Profile and Development Status of Flexion Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Flexion Therapeutics
-
Figure Sales and Growth Rate Analysis of Flexion Therapeutics
-
Figure Revenue and Market Share Analysis of Flexion Therapeutics
-
Table Product and Service Introduction of Flexion Therapeutics
-
Table Company Profile and Development Status of Eli Lilly
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly
-
Figure Sales and Growth Rate Analysis of Eli Lilly
-
Figure Revenue and Market Share Analysis of Eli Lilly
-
Table Product and Service Introduction of Eli Lilly
-
